Vol. 1 No. 2S (2007): CUAJ June-Supplement 1

View Vol. 1 No. 2S (2007): CUAJ June-Supplement 1

Published: 2012-12-11

Supplement-Introduction

Collaborations in renal cell carcinoma research

Lori A. Wood, Michael A.S. Jewett
- PDF

Review

Summary of the first annual Genitourinary Medical Oncology Conference Renal Cell Carcinoma Forum

Lori A. Wood, Bernard Escudier, Neil Reaume
- PDF
Current understanding of the molecular mechanisms of kidney cancer: a primer for urologists

Darwin L. Lim, Raymond Ko, Stephen E. Pautler
- PDF
Combining differential expression, chromosomal and pathway analyses for the molecular characterization of renal cell carcinoma

Kyle A. Furge, Karl Dykema, David Petillo, Michael Westphal, Zhongfa Zhang, Eric J. Kort, Bin Tean Teh
- PDF
Current status of cytokine therapy in management of patients with metastatic renal cell carcinoma

Anil K. Kapoor, Sébastien J. Hotte
- PDF
Systemic therapy for patients with advanced, unresectable or metastatic renal cell carcinoma: moving to guidelines

Sebastien J. Hotte, Anil K. Kapoor
- PDF
Sunitinib therapy for metastatic renal cell carcinoma: recommendations for management of side effects

Christian Kollmannsberger, D. Soulieres, R. Wong, A. Scalera, R. Gaspo, G. Bjarnason
- PDF
Locally advanced renal cell carcinoma

Mohammed Al Otaibi, Simon Tanguay
- PDF
New surgical horizons: the role of cytoreductive nephrectomy for metastatic kidney cancer

Ricardo A. Rendon
- PDF

Point-Counterpoint

Supplement-Conclusion

Renal cell carcinoma: currently the most interesting genitourinary malignancy

Lori A. Wood, Michael A.S. Jewett
- PDF